ARTICLE | Clinical News
LPLchip regulatory update
October 4, 2010 7:00 AM UTC
Progenika Biopharma’s U.S. subsidiary Progenika Inc. (Medford, Mass.) received CE Mark approval for its LPLchip to diagnose complete and partial lipoprotein lipase (LPL) deficiency. Progenika and Ams...